Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China flag China · Delayed Price · Currency is CNY
3.350
+0.030 (0.90%)
At close: Mar 10, 2026
-14.54%
Market Cap 6.35B
Revenue (ttm) 5.73B
Net Income (ttm) 77.12M
Shares Out 1.90B
EPS (ttm) 0.04
PE Ratio 87.82
Forward PE n/a
Dividend 0.06 (1.81%)
Ex-Dividend Date Sep 26, 2025
Volume 23,394,310
Average Volume 28,900,905
Open 3.340
Previous Close 3.320
Day's Range 3.320 - 3.360
52-Week Range 3.140 - 4.150
Beta 0.33
RSI 51.03
Earnings Date Apr 21, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China. [Read more]

Sector Healthcare
Founded 1995
Employees 5,059
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, SHE:002390's revenue was 6.03 billion, a decrease of -6.63% compared to the previous year's 6.46 billion. Earnings were 101.38 million, a decrease of -64.70%.

Financial Statements

News

There is no news available yet.